Imago BioSciences raises $80M to advance blood cancer therapy

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Nov 19, 2020 at 10:32 AM.

  1. #1 cafead, Nov 19, 2020 at 10:32 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,973
    Likes Received:
    3
    via Patients diagnosed with myeloproliferative neoplasm, a group of blood cancers in which the body overproduces red or white blood cells, don’t have great options. Treatment tends to be palliative, without changing the course of disease. Enter Imago BioSciences, which is working on a treatment that shuts down an enzyme important to cancer growth.

    article source
     
    Quote

Reply to Thread